06.06.2022 - NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) - Tiziana Life Sciences Ltd (NASDAQ: TLSA) ('Tiziana' or the 'Company'), a clinical-stage biopharmaceutical company enabling breakthrough immunotherapies via novel routes of administration today announced ...